Otros idiomas Uni-Bio Science Group Limited

Acciones

690 KYG9198H1406

Mercado cerrado - Hong Kong S.E. Otros sitios de cotización 10:09:00 03/05/2024			Varia. Cinco días.	Varia. 1 de enero.
0,084 ^HKD	-1,18 %		-1,18 %	+16,67 %

27/03	Uni-Bio Science Group Limited informa de los resultados de ganancias para el año completo finalizado el 31 de diciembre de 2023	CI
14/02	Los beneficios de Uni-Bio Science aumentarán en 2023	MT

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Uni-Bio Science Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023	27/03
Uni-Bio Science's Profit to Climb in 2023	14/02
Uni-Bio Science Group Limited Provides Unaudited Consolidated Earnings Guidance for the Year Ended 31 December 2023	14/02
Chinese Regulator NMPA Accepts Uni-Bio's Marketing Application for Eye Drops	23/01
Uni-Bio Science Group Limited Announces the Acceptance of its Marketing Application for Diquafosol Sodium Eye Drops by the China National Medical Products Administration	23/01
China Grants Uni-Bio Science's Injection for Orthopedic Diseases	22/01
Uni-Bio Science Group Limited Announces Approval of Marketing Application of Bogutai (Teriparatide Injection) by the China National Medical Products Administration	22/01
Uni-Bio Science Group Limited commences an Equity Buyback for 636,476,815 shares, representing 10% of its issued share capital, under the authorization approved on May 19, 2023.	13/12
Uni-Bio Science Group Limited Announces the Resignation of Ms. Zhang Yanfen as Executive Director	15/11
Uni-Bio Science's Unit Grants 7.2 Million Yuan Loan to Taili Biomedical Technology	18/09/23
Uni-Bio Science Group Limited Reports Earnings Results for the Half Year Ended June 30, 2023	28/08/23
Uni-Bio Science Group Limited Appoints Zhang Yanfen as an Executive Director	11/08/23
Uni Bio Science : Announces 2022 Annual Results，Record High Turnover of HK$440.3 Million and HK$38.5 Million Profit Achieved Expanding Portfolio with New Drug Innovations and Strategic R&D Partnerships	28/03/23
Uni-Bio Science Group Limited Reports Earnings Results for the Full Year Ended December 31, 2022	27/03/23
Uni-Bio Science Group Limited Provides Financial Guidance for the Year Ended 31 December 2022	06/03/23
Uni-Bio Science Unit Renews Property Lease for Two Years	23/12/22
Uni Bio Science : Interim Report 2022	12/09/22
Uni-Bio Science Group Limited Reports Earnings Results for the Half Year Ended June 30, 2022	29/08/22
Uni-Bio Science Group Limited Announces Marketing Application of Bogutai (Teriparatide Injection) Officially Accepted by the China National Medical Products Administration	29/06/22
Uni Bio Science : opens Hong Kong research centre,Future R&D focus in four major businesses	13/06/22

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Uni-Bio Science Group Limited

Acciones

690

KYG9198H1406

Otros idiomas

Filtros